| When: Thursday, 11/3/2022, 3:30 pm - 5:00 pm |
| Where: San Diego Convention Center-31ABC |
Description: The past 30 years have brought remarkable advances in our understanding of the biology of appetite and weight regulation. The leptin-melanocortin systems and gut peptides have emerged as key regulators of body weight homeostasis. How have these advances altered clinical practice? Attendees will learn how understanding of neuroendocrine regulation of appetite-regulation has progressed from discovery to clinical application for rare and common forms of obesity.
This session was jointly produced by The Obesity Society (TOS) and the Endocrine Society.
|
| Delivery Mechanism: Live In-Person |
| Keyword: Endocrine: Gut Peptides; Endocrine: Neuropeptides/Neurotransmitters; Treatment: Pharmacotherapy |
Track: Track 1: Metabolism and Integrative Physiology
|
|
|
Name |
Role |
Presentation |
 | Darleen Sandoval, PhD |
Chair |
Session Chair |
 | Simeon I. Taylor, MD, PhD |
CME Session Speaker |
Leptin: From Discovery to Clinic |
 | Donna H. Ryan, MD |
CME Session Speaker |
Setmelanotide: From Discovery to Clinic |
 | Richard E. Pratley, MD |
CME Session Speaker |
GLP-1 Analogs: From Discovery to Clinic |
| Darleen Sandoval, PhD |
Chair |
Moderate Panel Q&A |
| Simeon I. Taylor, MD, PhD |
CME Session Speaker |
Panel Q&A |
| Donna H. Ryan, MD |
CME Session Speaker |
Panel Q&A |
| Richard E. Pratley, MD |
CME Session Speaker |
Panel Q&A |
| Learning Objective: Understand the evidence-based science regarding neuroendocrine, environmental, endocrine, microbiota and/or cognitive behavioral mechanisms regulating energy balance and body weight. Apply that knowledge to develop and implement treatment options for adults and pediatric patients with overweight, obesity or obesity-related co-morbidities. |
|
|